Investors Target BioMimetic Over Bone Graft Statements
BioMimetic Therapeutics Inc. shareholders sued the biotechnology company Friday in Tennessee federal court, accusing its executives of puffing up the results of clinical trials for its star product, a synthetic bone...To view the full article, register now.
Already a subscriber? Click here to view full article